In vitro efficacy of 5-aminolevulic acid against Babesia gibsoni by solo-use and combined use with atovaquone

1) Baggish AL, Hill DR. Antiparasitic agent Atovaquone. Antimicrob Agents Chemother 46, 1163-1173, 2002.

2) Boozer AL, Macintire DK. Canine Babesiosis. Vet Clin North Am Small Anim Pract 33, 885- 904, 2003.

3) Homer MJ, Aguilar-Delfin Ⅰ, Telford Ⅲ SR, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 13, 451-469, 2000.

4) Iguchi A, Matsuu A, Ikadai H, Md H Talukder, Hikasa Y. Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cyt b. Vet Para 185, 145-150, 2012.

5) Iguchi A, Shiranaga N, Matsuu A, Hikasa Y. Efficacy of Malarone® in dogs naturally infected with Babesia gibsoni. J Vet Med Sci 76, 1291-1295, 2014.

6) Iguchi A, Soma T, Suzuki H, Xuan X. The epidemiological survey for atovaquone resistant related gene of Babesia gibsoni in Japan. J Vet Med Sci 78, 489-491, 2016.

7) Iguchi A, Soma T, Xuan X. Further epidemiological survey for atovaquone resistant related gene of Babesia gibsoni in Japan during 2015–2018. J Vet Med Sci 82, 1700-1703, 2020.

8) Komatsuya K, Hata M, Balogun EO, Hikosaka K, Suzuki S, Takahashi K, Tanaka T, Nakajima M, Ogura S, Sato S, Kita K. Synergy of ferrous ion on 5-aminolevulinic acid-mediated growth inhibition of Plasmodium falciparum. J Biochem 154, 501- 504, 2013.

9) Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother 44, 2100-2108, 2000.

10) Krik SK, Levy JK, Crawford PC. Efficacy of azithromycin and compounded atovaquone for treatment of Babesia gibsoni in dogs. J Vet Intern Med 31, 1108-1112, 2017.

11) Matsuu A, Koshida Y, Kawahara M, Inoue K, Ikadai H, Hikasa Y, Okano S, Higuchi S. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Vet Para 124, 9-18, 2004.

12) Matsuu A, Yamasaki M, Xuan X, Ikadai H, Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet Para 157, 1-8, 2008.

13) S u z u k i S , H i k os ak a K , Bal o gu n EO , Komatsuya K, Niikura M, Kobayashi F, Takahashi K, Tanaka T, Nakajima M, Kita K. In vivo curative and protective potential of orally administered 5-aminolevuliniv acid plus ferrous ion against Malaria. Antimicrob Agents Chemother 59, 6960-6967, 2015.

14) Suzuki K, Wakabayashi H, Takahashi M, Fukushima K, Yabuki S, Endo Y. A possible treatment strategy and clinical factors to estimate the treatment response in Babesia gibsoni infection. J Vet Med Sci 69, 563-568, 2007.